The global Migraine Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during.....
SynopsisThe global IT Solutions for Dialysis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of IT Solutions for Dialysis in various end use industries. The exp.....
SynopsisNeonatal ventilators provide ventilatory support to preterm and critically ill infants who suffer from respiratory failure and who generally have low-compliance lungs, small tidal volumes, high airway resistance, and high respiratory rates. Volume-targeted ven.....
SynopsisVortioxetine is an atypical antipsychotic and antidepressant indicated for the treatment of major depressive disorder (MDD). It is classified as a serotonin modulator and simulator (SMS) as it has a multimodal mechanism of action towards the serotonin neurotra.....
SynopsisPendred is defined as a rare inherited genetic disorder which is caused by mutations in a gene called SLC26A4 (formerly known as the PDS gene) on chromosome 7. It is categorized by bilateral sensorineural hearing loss and euthyroid goitre. This syndrome affect.....
SynopsisThe global CRISPR Gene Testing and Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in .....
SynopsisThe global Minimally Invasive Glaucoma Surgery Devices market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were co.....
Synopsis Cefaclor Capsules are a semisynthetic cephalosporin antibiotic for oral administration. It is used to treat certain infections caused by bacteria. Global Cefaclor Capsules market is projected to reach US$ million in 2029, increasing from.....
Synopsis Global Rehabilitation Assistive Devices market is projected to reach US$ 492 million in 2029, increasing from US$ 330 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COV.....
Synopsis Highlights The global Flurbiprofen Axetil Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of .....
